Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study

Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer

NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

NCT02567253 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

NCT00352755 ·Status: TERMINATED ·Phase: PHASE2

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

NCT01588964 ·Status: COMPLETED ·Phase: PHASE2

Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

NCT06535334 ·Status: NOT_YET_RECRUITING

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411 ·Status: COMPLETED ·Phase: PHASE1

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

NCT00968799 ·Status: TERMINATED ·Phase: NA

Intra-peritoneal Chemotherapy in Ovarian Cancer

NCT02861872 ·Status: UNKNOWN

Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

NCT03095001 ·Status: UNKNOWN ·Phase: PHASE2

Itraconazole in Advanced Ovarian Cancer

NCT05591560 ·Status: UNKNOWN ·Phase: NA

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors

NCT02604784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment

NCT02035345 ·Status: TERMINATED ·Phase: PHASE4

Treating Peritoneal Carcinomatosis With PIPAC

NCT02320448 ·Status: COMPLETED ·Phase: PHASE2

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

NCT00189371 ·Status: TERMINATED ·Phase: PHASE3

Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis

NCT02866903 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

NCT05185947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

NCT00005049 ·Status: COMPLETED ·Phase: PHASE2

International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

NCT06393543 ·Status: NOT_YET_RECRUITING

A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

NCT02004093 ·Status: COMPLETED ·Phase: PHASE2

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

NCT00003214 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

NCT02349958 ·Status: UNKNOWN ·Phase: PHASE2

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

NCT00426257 ·Status: COMPLETED ·Phase: PHASE3

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

NCT04329494 ·Status: RECRUITING ·Phase: PHASE1

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02272790 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer

NCT00919984 ·Status: TERMINATED ·Phase: PHASE2